ImmunologybioRxiv
Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis
C. Camacho-Toledano, I. Machin-Diaz, L. Calahorra…·D. Clemente
This study shows that baseline levels of monocytic-MDSCs predict fingolimod efficacy in MS patients and EAE mice.